Replies to post #933 on Zomedica Corp (ZOM)

[lecorb]

Zomedica Pharmaceuticals Corp (NYSE: ZOM) shares climbed 42.9% to $0.10 on Monday after tumbling 29% on Friday. Zomedica recently announced plans to develop gastrointestinal testing panel for TRUFORMA.September 22, 2020 (Benzinga)